Wednesday, 8 April 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Soleno Therapeutics Soars as Neurocrine Unveils $2.9B All-Cash Buyout at $53 a Share
6 Apr, 17:06 — 6 Apr, 17:06
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
1d ago
Soleno Therapeutics Soars as Neurocrine Unveils $2.9B All-Cash Buyout at $53 a Share
Read full article →
Something wrong with this story? Report an issue
Related Stories
Brian Poe calls for ‘people’s hearing’ on oil crisis, energy reforms
just now
Manila Water Prepares for Summer Heat and High Demand
just now
CHEd allows HEIs to shift to online classes amid oil crisis
just now
Philippine Lottery Draws Yield No Jackpot Winners on April 8
just now
Wednesday, 8 April 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
